{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:12:51Z","timestamp":1793707971290,"version":"4.6.1"},"reference-count":48,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish Cancer Research Funds of Radiumhemmet (Radiumhemmets Forskningsfonder)","award":["221091"],"award-info":[{"award-number":["221091"]}]},{"name":"Swedish Cancer Research Funds of Radiumhemmet (Radiumhemmets Forskningsfonder)","award":["10970"],"award-info":[{"award-number":["10970"]}]},{"name":"Swedish Cancer and Allergy Foundation (Cancer-och allergifonden)","award":["221091"],"award-info":[{"award-number":["221091"]}]},{"name":"Swedish Cancer and Allergy Foundation (Cancer-och allergifonden)","award":["10970"],"award-info":[{"award-number":["10970"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/objectives: Non-small cell lung cancer and pleural mesothelioma are among the most lethal and therapy-resistant tumors in humans. These tumors are diagnosed late, frequently present pleural effusion and develop drug resistance, and the treatment is often inefficient and largely alliative. Therefore, there is an urgent need to refine the selection of drugs and patients for personalized treatment. Methods: To progress the field, we performed a systematic literature review in line with the PRISMA guidelines followed by a narrative synthesis approach to identify themes. Results: The literature to date shows, in general, a positive correlation between the drug-sensitivity of patient-derived cells ex vivo and the clinical outcome. However, only a handful of these studies show a numerical correlation. This, along with the vast diversity of correlated techniques and parameters makes it difficult to directly compare the findings. To build a common knowledge base for future studies, we therefore offer a comprehensive summary of the literature, identify gaps, and suggest future avenues for research. Conclusions: We present unified recommendations for the collection, preparation, and ex vivo sensitivity testing of samples for the future development of personalized medicine.<\/jats:p>","DOI":"10.3390\/cancers17060986","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T15:24:56Z","timestamp":1742225096000},"page":"986","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1880-3261","authenticated-orcid":false,"given":"Jenny","family":"Zipprick","sequence":"first","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-7740","authenticated-orcid":false,"given":"Enes","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-3503","authenticated-orcid":false,"given":"Hanna","family":"Krynska","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0168-3199","authenticated-orcid":false,"given":"S\u0131la","family":"K\u00f6pr\u00fcl\u00fco\u011flu","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Strau\u00df","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-6426","authenticated-orcid":false,"given":"Marcus","family":"Skribek","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Hutyra-Gram \u00d6tv\u00f6s","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-9129","authenticated-orcid":false,"given":"Annica K. B.","family":"Gad","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Dobra","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, 171 77 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The Effect of Advances in Lung-Cancer Treatment on Population Mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: Current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4143\/crt.2022.264","article-title":"Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015","volume":"55","author":"Jeon","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Yang","year":"2008","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"82885","DOI":"10.18632\/oncotarget.20889","article-title":"Ex Vivo Evaluation of Tumor Cell Specific Drug Responses in Malignant Pleural Effusions","volume":"8","author":"Hillerdal","year":"2017","journal-title":"Oncotarget"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18632\/genesandcancer.56","article-title":"Drug Sensitivity Profiling and Molecular Characteristics of Cells from Pleural Effusions of Patients with Lung Adenocarcinoma","volume":"6","author":"Szulkin","year":"2015","journal-title":"Genes Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acsbiomaterials.8b01356","article-title":"Pleural Effusion Aspirate for use in 3D Lung Cancer Modeling and Chemotherapy Screening","volume":"5","author":"Mazzocchi","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41698-023-00463-z","article-title":"The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients","volume":"7","author":"Akerlund","year":"2023","journal-title":"NPJ Precis. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100463","DOI":"10.1016\/j.ctarc.2021.100463","article-title":"Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitors","volume":"29","author":"Kaur","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/cas.14749","article-title":"Similarities and differences in metabolites of tongue cancer cells among two- and three-dimensional cultures and xenografts","volume":"112","author":"Murakami","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-022-00285-w","article-title":"Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines","volume":"10","author":"Tidwell","year":"2022","journal-title":"Cancer Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"300060520955058","DOI":"10.1177\/0300060520955058","article-title":"Personalized drug testing in a patient with non-small-cell lung cancer using cultured cancer cells from pleural effusion","volume":"48","author":"Wu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1871520617666170419123713","article-title":"Evaluation of the in vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer using the ATP-TCA","volume":"18","author":"Chen","year":"2018","journal-title":"Anticancer. Agents Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/0008-5472.CAN-16-1121","article-title":"Ex Vivo Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy","volume":"77","author":"Karekla","year":"2017","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/cncr.22601","article-title":"Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer","volume":"109","author":"Moon","year":"2007","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Szulkin, A., Otv\u00f6s, R., Hillerdal, C.-O., Celep, A., Yousef-Fadhel, E., Skribek, H., Hjerpe, A., Sz\u00e9kely, L., and Dobra, K. (2014). Characterization and Drug Sensitivity Profiling of Primary Malignant Mesothelioma Cells from Pleural Effusions. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-709"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.21873\/anticanres.13920","article-title":"Feasibility Technique of Low-passage In Vitro Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome","volume":"39","author":"Vinayanuwattikun","year":"2019","journal-title":"Anticancer. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00595-017-1594-7","article-title":"Collagen gel droplet-embedded culture drug sensitivity test for adjuvant chemotherapy after complete resection of non-small-cell lung cancer","volume":"48","author":"Inoue","year":"2018","journal-title":"Surg. Today"},{"key":"ref_25","first-page":"5181","article-title":"Individualized Chemotherapy for Patients with Non-Small Cell Lung Cancer by Prospective Identification of Neuroendocrine Markers and in Vitro Drug Sensitivity Testing","volume":"53","author":"Shaw","year":"1993","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jcb.240630513","article-title":"Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non-small cell lung cancer and small cell lung cancer","volume":"24","author":"Shaw","year":"1996","journal-title":"J. Cell Biochem. Suppl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2206603","DOI":"10.1002\/advs.202206603","article-title":"Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics","volume":"10","author":"Shie","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Clohessy, J.G., and Pandolfi, P.P. (2018). The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00340"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: An emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"FSO190","DOI":"10.4155\/fsoa-2017-0003","article-title":"Ex vivo tumor culture systems for functional drug testing and therapy response prediction","volume":"3","author":"Meijer","year":"2017","journal-title":"Future Sci. OA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1016\/j.celrep.2017.11.051","article-title":"Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care","volume":"21","author":"Kodack","year":"2017","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Papp, E., Steib, A., Abdelwahab, E.M., Meggyes-Rapp, J., Jakab, L., Smuk, G., Schlegl, E., Moldvay, J., Sarosi, V., and Pongracz, J.E. (2020). Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas. BMJ Open Respir. Res., 7.","DOI":"10.1136\/bmjresp-2019-000505"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kim, S.Y., Lee, J.Y., Kim, D.H., Joo, H., Yun, M.R., Jung, D., Yun, J., Heo, S.G., Ahn, B., and Park, C.W. (2019). Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-56356-4"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12967-016-0816-x","article-title":"Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity","volume":"14","author":"Roscilli","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.lungcan.2009.07.005","article-title":"Prediction of Chemotherapeutic Effect on Postoperative Recurrence by in Vitro Anticancer Drug Sensitivity Testing in Non-Small Cell Lung Cancer Patients","volume":"68","author":"Higashiyama","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00280-006-0292-8","article-title":"Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST)","volume":"59","author":"Kawamura","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_37","first-page":"279","article-title":"Cisplatin-Based Chemotherapy for Postoperative Recurrence in Non-Small Cell Lung Cancer Patients: Relation of the in Vitro Chemosensitive Test to Clinical Response","volume":"8","author":"Higashiyama","year":"2001","journal-title":"Oncol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bjc.1992.5","article-title":"Chemotherapy of Non-Small Cell Lung Carcinoma Guided by an in Vitro Drug Resistance Assay Measuring Total Tumour Cell Kill","volume":"65","author":"Wilbur","year":"1992","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1200\/JCO.1987.5.12.1912","article-title":"Comparison between Clinical Response and in Vitro Drug Sensitivity of Primary Human Tumors in the Adhesive Tumor Cell Culture System","volume":"5","author":"Ajani","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gilazieva, Z., Ponomarev, A., Rutland, C., Rizvanov, A., and Solovyeva, V. (2020). Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine. Cancers, 12.","DOI":"10.3390\/cancers12102727"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.eng.2021.04.024","article-title":"The Fibrillar Matrix: Novel Avenues for Breast Cancer Detection and Treatment","volume":"7","author":"Rezk","year":"2021","journal-title":"Engineering"},{"key":"ref_42","first-page":"3015","article-title":"Deconstructing the third dimension: How 3D culture microenvironments alter cellular cues","volume":"125","author":"Baker","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nmat4444","article-title":"Cell-mediated fibre recruitment drives extracellular matrix mechanosensing in engineered fibrillar microenvironments","volume":"14","author":"Baker","year":"2015","journal-title":"Nat. Mater."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Nazemi, M., and Rainero, E. (2020). Cross-Talk Between the Tumor Microenvironment, Extracellular Matrix, and Cell Metabolism in Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00239"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-18-1367","article-title":"Diverse Functions of Macrophages in Different Tumor Microenvironments","volume":"78","author":"ang","year":"2018","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100965","DOI":"10.1016\/j.crmeth.2025.100965","article-title":"A thermoplastic chip for 2D and 3D correlative assays combining screening and high-resolution imaging of immune cell responses","volume":"5","author":"Verron","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"eadq6830","DOI":"10.1126\/sciadv.adq6830","article-title":"Ex Vivo Modeling of Precision Immuno-Oncology Responses in Lung Cancer","volume":"10","author":"Alsaed","year":"2024","journal-title":"Sci. Adv."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/6\/986\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:53:58Z","timestamp":1760028838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/6\/986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["cancers17060986"],"URL":"https:\/\/doi.org\/10.3390\/cancers17060986","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}